UKayentis, uchwepheshe womhlaba wonke ekubanjweni kwedatha ye-elekthoni yeziguli ezivivinyweni zomtholampilo, usiza abaxhasi kanye nama-CRO ukuletha ukulula, ukusebenza kahle kanye nekhwalithi ekuqoqweni kwedatha yesivivinyo somtholampilo kusuka ezigulini nakwamasayithi.

IGrenoble, eFrance, Septhemba 3, 2019 - Kayentis, umhlinzeki womhlaba wonke wezixazululo ze-eCOA (i-electronic Clinical Outcome Assessment) ngezivivinyo zomtholampilo, namuhla umemezela ukuqokwa kuka-Estelle Haenel, PharmD noPh.D, njengomqondisi wezokwelapha.

Unksz Haenel uletha amaKayentis ngaphezu kweminyaka engu-25 yeminyaka yemikhakha yama-pharma, kufaka phakathi iminyaka ye-18 kwisayensi yemitholampilo nokusebenza, azosebenzisa ukuhlanganisa ubungcweti besayensi kuyo yonke imikhakha ebanzi yenkampani yezokwelapha. Njengokubaluleke kakhulu, uzoletha engaphambili kweqhinga lenkampani imibono yeziguli, amasayithi namakhasimende. Lo mgomo wokuqondisa uhloselwe ukuthuthukisa ukubandakanyeka kweziguli ezivivinyweni zokwelashwa, ngaleyo ndlela kusize amakhemikhali, ama-biotech kanye nama-CRO ukufezekisa izidingo ezandayo zokulawula idatha eyengeziwe nezifundo eziningi zeziguli. Indima yakhe ifaka ukulekelela ukwakhiwa kweziza zombili 'kanye nokwamukela iziguli izisombululo ze-eCOA njengoba lobu buchwepheshe buvuthiwe. Inothi kuzoba yingxenyekazi entsha ye-eCOA yesizukulwane esisha se-Kayentis - I-Clinform3 - eklanyelwe ukuthuthukisa ukubandakanyeka kweziguli, ukuxhumana namadivayisi ezokwelapha nokugqoka, kanye nokuqaliswa kwe-BYOD.

UNkk Haenel uzophinde abe ngummeleli kaKayentis e-ePRO Consortium, avumele inkampani ukuthi ibambe iqhaza elibonakalayo ekwakheni nasekusebenziseni izindlela ezihamba phambili emkhakheni we-eCOA, kanye nokuvumela uKayentis ukuthi abelane ngolwazi lwakhe nobungoti bakhe ngokusebenzisa izinkundla ezisebenza ngobuchwepheshe.

"UKayentis uyakujabulela ukwamukela u-Estelle," kusho uGuillaume Juge, oyisikhulu esiphezulu kwaKayentis. "Uletha ulwazi olubanzi lwemboni yama-pharma namakhono asezingeni eliphakeme azothuthukisa ulwazi lwethu lwezempilo, athuthukise ukugxila kwethu futhi aqinise ikhwalithi yokunakekelwa esikuhlinzeka ezingosini nasezigulini. Uzobamba iqhaza elikhulu ekusizeni amakhasimende ethu kulo lonke elaseYurophu, eNyakatho Melika nase-Asia aqhamuke futhi enze izifundo zokuqokelelwa kwedatha yokuqanjwa kwedatha eqine kakhulu. ”

IKayentis igxile ezigabeni IIB / III futhi iya ngokuya ikhulisa izinsizakalo zayo ezifundweni zesigaba sekwephuzile kanye neReal-World Evidence (RWE). Iqhube ukuqoqwa kwedatha yedijithali ngaphezulu kokuhlolwa okungama-200 kwemitholampilo emazweni angama-75 (amasayithi angama-9,000 neziguli ezingama-70,000) isebenzisa izilimi ezingama-90 ezahlukahlukene ezindaweni zokwelashwa: i-oncology, i-ophthalmology, i-dermatology, i-cardiovascular, i-immunology, i-pediatrics kanye ne-neuroscience / CNS, phakathi abanye.

“Ukukhula kukaKayentis bekuhlaba umxhwele. Lokhu kungenxa yekhwalithi, amandla nokuzinikela kwamaqembu ayo, ”kusho u-Estelle Haenel, umqondisi wezokwelapha e-Kayentis. "Ekubhekeni kwayo njenge-100% eCOA, igxile ekuqeqesheni abasebenzi ngokuzinikela ngokuphelele ekuhleleni, ekuletheni nasekulondolozeni izixazululo ze-eCOA kumakhasimende. Ngiyazethemba izixazululo ezisezingeni eliphakeme nezisezingeni eliphakeme ze-CAOA zokusekela izivivinyo zomtholampilo ezisebenza kahle. Uma kunikezwe isimo samanje sokudluliswa kobuchwepheshe obusha ezigulini, kubaluleke kakhulu ukuba nezinhlangano ezisencane nezishintshayo ezinikelwe, futhi zinolwazi, lokuqoqa nokuphatha imininingwane yesiguli ngogesi. ”

Ngesikhathi sikaNks Haenel iminyaka engaphezulu kwe-25 yeminyaka embonini yezemithi, ocwaningweni lwangaphambi kokugula nokwelashwa, usebenze kuzo zombili izinkampani ze-biotech kanye ne-pharma enkulu, kufaka phakathi uPfizer, ayijoyina ekuqaleni kwe2012. Uhole amaphrojekthi kusuka esigabeni 1 ngokusebenzisa i-4 ezindaweni eziningi zokwelapha futhi anikeze ukuholwa nobuchwepheshe besayensi yemitholampilo nokusebenza kwemitholampilo. Ubuye abe nobungcweti ocwaningweni olungathathi hlangothi lomtholampilo kanye nasekhemisi yemitholampilo. Unksz Haenel uthole i-PharmD eParis V René Descartes University e-1994 kanye ne-Ph.D kwi-Molecular and Cellular Biology from Paris Sud University e-2000. Ushicilele amaphepha amaningana esayensi.